title: Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study.
authors.forename: T
authors.initials: T
authors.lastname: Thiele
authors.forename: A
authors.initials: A
authors.lastname: Sümnig
authors.forename: G
authors.initials: G
authors.lastname: Hron
authors.forename: C
authors.initials: C
authors.lastname: Müller
authors.forename: K
authors.initials: K
authors.lastname: Althaus
authors.forename: H W S
authors.initials: HW
authors.lastname: Schroeder
authors.forename: A
authors.initials: A
authors.lastname: Greinacher
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D000077144:Clopidogrel; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004630:Emergencies; D004632:Emergency Medical Services; D005260:Female; D005858:Germany; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000493:pharmacokinetics*; D017713:Platelet Transfusion / Q000009:adverse effects; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D011300:Preoperative Care; D018570:Risk Assessment; D012307:Risk Factors; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin